cDepartment of Ageing Health and Stroke, Guy's and St Thomas' National Health Service Foundation Trust and King's College London, United Kingdom ...
A woman in her 40s presented with progressive cognitive decline, expressive language difficulty and episodic confusion. Her initial symptoms were misattributed to psychiatric illness, and later to ...
Mobile stroke units (MSU) enable rapid identification and treatment of thrombolytic-eligible patients with acute ischemic stroke (AIS). Recent studies have highlighted the benefit of MSUs over ...
This study aims to provide a narrative review of the influence of SES on stroke, following a timeline structure of stroke: it begins by addressing stroke occurrence, access to and quality of acute ...
Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
OCEANIC-STROKE shows asundexian cuts ischemic stroke recurrence by 26% in patients taking standard antiplatelet therapy, with no major bleeding increase. Asundexian is a direct oral inhibitor of FXIa ...
Found in everything from protein bars to energy drinks, erythritol has long been considered a safe alternative to sugar. But research suggests this widely used sweetener may be quietly undermining one ...
A popular "natural" sugar substitute found in thousands of diet foods and drinks may be damaging the brain's protective barrier and increasing stroke risk, according to research from the University of ...
A long-term study found that women who closely followed a Mediterranean diet had a much lower risk of stroke. The strongest benefits were seen in women who ate more plant-based foods, fish, and olive ...
NEW ORLEANS, LA—Adding the factor XIa inhibitor asundexian (Bayer) to antiplatelet therapy tops antiplatelet therapy alone for preventing ischemic strokes in patients with acute noncardioembolic ...
For many stroke survivors, recovery is derailed by painful muscle stiffness and involuntary spasms that limit movement, independence, and quality of life. Often viewed as an unavoidable consequence of ...
FRANKFURT, Feb 5 (Reuters) - Bayer (BAYGn.DE), opens new tab said on Thursday its experimental blood thinner cut the risk of stroke recurrence by 26% in a late-stage trial, in a fresh boost for CEO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results